| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.043 | 0.1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |